Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting
2018 · Acta Pharmaceutica Sinica B · 94 citations
https://doi.org/10.1016/j.apsb.2018.11.005
F
Fengling Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
182
Papers
3.1K
Citations
31
h-index
79
i10-index
Fengling Wang is an academic researcher from Sichuan University. The author has contributed to research in topics: Natural product bioactivities and synthesis & CAR-T cell therapy research & Nanoparticle-Based Drug Delivery. The author has an h-index of 31, co-authored 155 publications.
ORCID: 0000-0002-7416-6957Papers by this author
worksA global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024 · Hepatology International · 29 citations
https://doi.org/10.1007/s12072-024-10702-5
Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
2019 · Neoplasia · 26 citations
https://doi.org/10.1016/j.neo.2019.03.013
Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention
2017 · Scientific Reports · 13 citations
https://doi.org/10.1038/srep45023
Autophagy responsive intra-intercellular delivery nanoparticles for effective deep solid tumor penetration
2022 · Journal of Nanobiotechnology · 12 citations
https://doi.org/10.1186/s12951-022-01514-6
Synthesis of gypsogenin derivatives with capabilities to arrest cell cycle and induce apoptosis in human cancer cells
2018 · Royal Society Open Science · 10 citations
https://doi.org/10.1098/rsos.171510
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat